UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dosimetric Benefits of Intensity-Modulated Radiotherapy Combined With the Deep-Inspiration Breath-Hold Technique in Patients With Mediastinal Hodgkin's Lymphoma

International journal of radiation oncology, biology, physics, 2012-03, Vol.82 (4), p.1522-1527

2012

Volltextzugriff (PDF)

Lung stereotactic body radiation therapy: personalized PTV margins according to tumor location and number of four-dimensional CT scans

Radiation oncology (London, England), 2022-01, Vol.17 (1), p.5-5, Article 5

2022

Volltextzugriff (PDF)

Involved-Node Radiotherapy and Modern Radiation Treatment Techniques in Patients With Hodgkin Lymphoma

International journal of radiation oncology, biology, physics, 2011-05, Vol.80 (1), p.199-205

2011

Volltextzugriff (PDF)

Low-Dose Radiation Treatment in Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma: A Plausible Approach? A Single-Institution Experience in 10 Patients

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (3), p.e385-e389

2012

Volltextzugriff (PDF)

IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?

Radiotherapy and oncology, 2011-04, Vol.99 (1), p.73-78

2011

Volltextzugriff (PDF)

Treatment related factors associated with the risk of breast radio-induced-sarcoma

Radiotherapy and oncology, 2022-06, Vol.171, p.14-21

2022

Volltextzugriff (PDF)

Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.370-370

2023

Volltextzugriff (PDF)

Preoperative chemoradiation (CRT) with carboplatin (CBP)/paclitaxel (PCL) (CP) or with 5-fluorouracil (FU)/oxaliplatin (OX) (Fx) for esophageal or junctional cancer: A randomized phase 2 trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4015-4015

2022

Volltextzugriff (PDF)

Application of gated FDG PET/CT in target volume definition for radiotherapy in esophageal cancer

Annals of oncology, 2017-06, Vol.28, p.iii31-iii31

2017

Volltextzugriff (PDF)

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial

BMC cancer, 2016-05, Vol.16 (1), p.318, Article 318

2016

Volltextzugriff (PDF)

Radiotherapy in small-cell lung cancer: Where should it go?

Lung cancer (Amsterdam, Netherlands), 2010-08, Vol.69 (2), p.133-140

2010

Volltextzugriff (PDF)

The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines

Radiotherapy and oncology, 2008-08, Vol.88 (2), p.202-210

2008

Volltextzugriff (PDF)

Post-operative radiation therapy

Translational lung cancer research, 2013-10, Vol.2 (5), p.423-432

2013

Volltextzugriff (PDF)

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18 F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)

Journal of Nuclear Medicine, 2017-07, Vol.58 (7), p.1045-1053

2017

Volltextzugriff (PDF)

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by ^sup 18^F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)

The Journal of nuclear medicine (1978), 2017-07, Vol.58 (7), p.1045

2017

Volltextzugriff (PDF)

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)

The Journal of nuclear medicine (1978), 2017-07, Vol.58 (7), p.1045-1053

2017

Volltextzugriff (PDF)

A Phase I dose escalation trial using Intensity-Modulated Radiotherapy with simultaneous integrated boost in Pelvic Chemoradiotherapy for Metastatic Rectal Cancer

Journal of Cancer Science and Clinical Therapeutics, 2021, Vol.5 (3)

2021

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dosimetric Benefits of Intensity-Modulated Radiotherapy Combined With the Deep-Inspiration Breath-Hold Technique in Patients With Mediastinal Hodgkin's Lymphoma

Lung stereotactic body radiation therapy: personalized PTV margins according to tumor location and number of four-dimensional CT scans

Involved-Node Radiotherapy and Modern Radiation Treatment Techniques in Patients With Hodgkin Lymphoma

Low-Dose Radiation Treatment in Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma: A Plausible Approach? A Single-Institution Experience in 10 Patients

IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial

Treatment related factors associated with the risk of breast radio-induced-sarcoma

Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT

Preoperative chemoradiation (CRT) with carboplatin (CBP)/paclitaxel (PCL) (CP) or with 5-fluorouracil (FU)/oxaliplatin (OX) (Fx) for esophageal or junctional cancer: A randomized phase 2 trial

Application of gated FDG PET/CT in target volume definition for radiotherapy in esophageal cancer

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial

Radiotherapy in small-cell lung cancer: Where should it go?

The conundrum of hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines

Post-operative radiation therapy

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18 F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by ^sup 18^F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)

A Phase I dose escalation trial using Intensity-Modulated Radiotherapy with simultaneous integrated boost in Pelvic Chemoradiotherapy for Metastatic Rectal Cancer

Post-Operative Radiotherapy (PORT) Versus No PORT in Patients With Completely Resected Non-Small Cell Lung Cancer and Proven Mediastinal N2 Involvement: An Open Label Randomised Phase 3 Superiority Trial (Lung ART (IFCT-0503, UK NCRI, SAKK))

Suchergebnisse filtern